Nicholas Kitchin is Vice President in Pfizer’s Vaccine Clinical Research and Development group. Dr. Kitchin joined Pfizer in 2011, and currently provides global medical oversight of development programs for the company’s COVID-19 vaccine (including combinations) and Clostridioides difficile vaccine. Dr. Kitchin obtained his medical degree from the University of London in 1991 and is a Fellow of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom. After initial training in anaesthesiology, Dr. Kitchin joined the pharmaceutical industry in 1994, and since 1998 has specialized in the field of vaccines. Having had a wide variety of roles in this area, he is a passionate advocate for the public health benefits of vaccination.